Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - US5500211090 - Common Stock

140.94 EUR
+0.2 (+0.14%)
Last: 9/10/2025, 7:00:00 PM
Fundamental Rating

7

Overall 33L gets a fundamental rating of 7 out of 10. We evaluated 33L against 46 industry peers in the Textiles, Apparel & Luxury Goods industry. 33L gets an excellent profitability rating and is at the same time showing great financial health properties. 33L is not valued too expensively and it also shows a decent growth rate. These ratings could make 33L a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
In the past year 33L had a positive cash flow from operations.
Each year in the past 5 years 33L has been profitable.
In the past 5 years 33L always reported a positive cash flow from operatings.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

33L has a better Return On Assets (24.33%) than 97.83% of its industry peers.
33L has a better Return On Equity (42.14%) than 93.48% of its industry peers.
The Return On Invested Capital of 33L (30.42%) is better than 97.83% of its industry peers.
33L had an Average Return On Invested Capital over the past 3 years of 29.73%. This is significantly above the industry average of 11.06%.
The last Return On Invested Capital (30.42%) for 33L is above the 3 year average (29.73%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 24.33%
ROE 42.14%
ROIC 30.42%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

33L has a better Profit Margin (16.82%) than 89.13% of its industry peers.
In the last couple of years the Profit Margin of 33L has remained more or less at the same level.
With an excellent Operating Margin value of 23.40%, 33L belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
33L's Operating Margin has been stable in the last couple of years.
33L's Gross Margin of 59.34% is in line compared to the rest of the industry. 33L outperforms 45.65% of its industry peers.
In the last couple of years the Gross Margin of 33L has remained more or less at the same level.
Industry RankSector Rank
OM 23.4%
PM (TTM) 16.82%
GM 59.34%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 33L is creating value.
The number of shares outstanding for 33L has been reduced compared to 1 year ago.
The number of shares outstanding for 33L has been reduced compared to 5 years ago.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 7.42. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.42, 33L belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.42
ROIC/WACC3.14
WACC9.7%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

33L has a Current Ratio of 2.28. This indicates that 33L is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.28, 33L is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
33L has a Quick Ratio of 1.23. This is a normal value and indicates that 33L is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 33L (1.23) is better than 71.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 1.23
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

6

3. Growth

3.1 Past

33L shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.19%, which is quite good.
The Earnings Per Share has been growing by 24.37% on average over the past years. This is a very strong growth
Looking at the last year, 33L shows a quite strong growth in Revenue. The Revenue has grown by 9.39% in the last year.
Measured over the past years, 33L shows a very strong growth in Revenue. The Revenue has been growing by 21.62% on average per year.
EPS 1Y (TTM)13.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%2.36%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.32%

3.2 Future

Based on estimates for the next years, 33L will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.14% on average per year.
The Revenue is expected to grow by 6.76% on average over the next years.
EPS Next Y0.54%
EPS Next 2Y3.51%
EPS Next 3Y4.14%
EPS Next 5Y10.14%
Revenue Next Year6.07%
Revenue Next 2Y6.42%
Revenue Next 3Y6.25%
Revenue Next 5Y6.76%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.18, the valuation of 33L can be described as reasonable.
33L's Price/Earnings ratio is rather cheap when compared to the industry. 33L is cheaper than 86.96% of the companies in the same industry.
33L's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.03.
A Price/Forward Earnings ratio of 10.48 indicates a reasonable valuation of 33L.
Based on the Price/Forward Earnings ratio, 33L is valued cheaply inside the industry as 93.48% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.54. 33L is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.18
Fwd PE 10.48
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

71.74% of the companies in the same industry are more expensive than 33L, based on the Enterprise Value to EBITDA ratio.
33L's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.03
EV/EBITDA 6.19
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 33L does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)20.73
PEG (5Y)0.46
EPS Next 2Y3.51%
EPS Next 3Y4.14%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (9/10/2025, 7:00:00 PM)

140.94

+0.2 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)12-03 2025-12-03/amc
Inst Owners96.18%
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap16.89B
Analysts73.85
Price Target248.02 (75.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-1.37%
Max EPS beat(2)2.91%
EPS beat(4)3
Avg EPS beat(4)2.92%
Min EPS beat(4)-1.37%
Max EPS beat(4)5.41%
EPS beat(8)7
Avg EPS beat(8)3.97%
EPS beat(12)10
Avg EPS beat(12)5.1%
EPS beat(16)14
Avg EPS beat(16)6.97%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.92%
Revenue beat(4)0
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)4
Avg Revenue beat(12)-0.36%
Revenue beat(16)6
Avg Revenue beat(16)0.12%
PT rev (1m)-9.33%
PT rev (3m)-16.55%
EPS NQ rev (1m)-0.46%
EPS NQ rev (3m)-1.92%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 11.18
Fwd PE 10.48
P/S 1.84
P/FCF 15.03
P/OCF 9.76
P/B 4.61
P/tB 4.81
EV/EBITDA 6.19
EPS(TTM)12.61
EY8.95%
EPS(NY)13.45
Fwd EY9.55%
FCF(TTM)9.38
FCFY6.65%
OCF(TTM)14.44
OCFY10.25%
SpS76.62
BVpS30.57
TBVpS29.3
PEG (NY)20.73
PEG (5Y)0.46
Profitability
Industry RankSector Rank
ROA 24.33%
ROE 42.14%
ROCE 42.93%
ROIC 30.42%
ROICexc 39.31%
ROICexgc 40.92%
OM 23.4%
PM (TTM) 16.82%
GM 59.34%
FCFM 12.24%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 152.77%
Cap/Sales 6.61%
Interest Coverage 250
Cash Conversion 67.98%
Profit Quality 72.77%
Current Ratio 2.28
Quick Ratio 1.23
Altman-Z 7.42
F-Score8
WACC9.7%
ROIC/WACC3.14
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%2.36%
EPS Next Y0.54%
EPS Next 2Y3.51%
EPS Next 3Y4.14%
EPS Next 5Y10.14%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.32%
Revenue Next Year6.07%
Revenue Next 2Y6.42%
Revenue Next 3Y6.25%
Revenue Next 5Y6.76%
EBIT growth 1Y12.36%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year19.97%
EBIT Next 3Y9.65%
EBIT Next 5Y9.02%
FCF growth 1Y122.59%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y61.42%
OCF growth 3Y17.83%
OCF growth 5Y27.7%